Audit Report Tv)
Report No: 0713308726
Version 1

Product Service

2.5.11 Production and Service Controls - #90464 (RevalstraRe / Central Supply Hoses)

Subsystem Production and Service Controls - #90464 (RevalstraRe / Central Supply Hoses)
Audit trail Martin Szepannek
records of
Area(s) visited | Location# 90464 (Revalstrake)
(location, e.g., | For more details related to audit location and time refer to chapter 2.2 of this report.
site visited)

Audit criteria
according to

“Production and Service Controls: Planning of Production and Service Process (MDSAP Chapter 6, Task 1, Site: 10578);
(DIN)(EN) ISO 13485 - 7.1, 7.2.1, 7.5.1 + (DIN)(EN) ISO 9001 - 8.1, 8.2.2, 8.5.1 + MDSAP - Australia - TG(MD)R Sch 1 P1 2, Sch3 P1 C11.4(4), Sch3 P1
CI1.4(5)(d)&(e) + MDSAP - Brazil - RDC ANVISA 16/2013: 2.2.1, 2.4, 4.1.2, 4.1.7, 5.1 + MDSAP - Japan - MO169: 26, 27, 40 + MDSAP - USA - 21 CFR 801,

audit plan 820.30(b), 820.20(a), 820.30(h), 820.70(a), 830 + MDR - Article 10.9 [3 (g) + MDD - Annex II (3.2), Annex V (3.2)"
Production and Service Controls: Selection of Production and Service Process(es) (MDSAP Chapter 6, Task 2, Site: 10578
"Production and Service Controls: Infrastructure (MDSAP Chapter 6, Task 5, Site: 10578);
(DIN)(EN) ISO 13485 - 4.2.1, 6.3, 7.5.1 + (DIN)(EN) ISO 9001 - 7.1.3, 7.5.1, 8.5.1 + MDSAP - Brazil - RDC ANVISA 16/2013: 5.1.2, 5.1.5 + MDSAP - Canada -
CMDR 14 + MDSAP - Japan - MO169: 6, 24, 40 + MDSAP - USA - 21 CFR 820.70(g), 820.70(f) + MDR - Annex IX2.2 11”
"Production and Service Controls: Work Environment (MDSAP Chapter 6, Task 6, Site: 10578);
(DIN)(EN) ISO 13485 - 4.2.1, 6.4 + (DIN)(EN) ISO 9001 - 7.1.4, 7.5.1 + MDSAP - Australia - TG(MD)R Sch1 P2 7.2, 8 + MDSAP - Brazil - RDC ANVISA
16/2013: 5.1.3 + MDSAP - Japan - MO169: 6, 25-1, 25-2; [Old: 6, 25] + MDSAP - USA - 21 CFR 820.70(c), 820.70(d), 820.70(e) + MDR - Annex IX2.2 1;
Annex | (11) + MDD - Annex II (3.2), Annex V (3.2)"
"Production and Service Controls: Identification of Processes Subject to Validation (MDSAP Chapter 6, Task 7, Site: 10578);
(DIN)(EN) ISO 13485 - 4.2.1, 4.1.6, 7.5.6 + (DIN)(EN) ISO 9001 - 4.4, 7.5.1, 8.4, 8.5.1 + MDSAP - Australia - TG(MD)R Sch1 P2 8.2, 8.3; Sch3 P1 1.4(5)(d)_ +
MDSAP - Brazil - RDC ANVISA16/2013: 5.5.2, 5.5.3 + MDSAP - Japan - M0169: 6, 5-6, 45; [Old: 6, 45] + MDSAP - USA - 21 CFR 820.75(a) + MDR - Annex
IX 2.2 2 (d); Annex XI 6.2 ]2, 12"
"Production and Service Controls: Monitoring and Measurement of Product Conformity (MDSAP Chapter 6, Task 10, Site: 10578);
(DIN)(EN) ISO 13485 - 7.1, 7.5.1, 8.1, 8.2.6 + (DIN)(EN) ISO 9001 - 8.1, 8.5.1, 8.6, 9.1.1 + MDSAP - Australia - TG(MD)R Sch1 P1 2, Sch3 P1 1.4(5)(b)&(e) +
MDSAP - Brazil - RDC ANVISA 16/2013: 2.4, 5.1.1, 9.1 + MDSAP - Japan - MO169: 26, 40, 54, 58,59. + MDSAP - USA - 21 CFR 820.70(a), 820.250(a) +
MDR - Article 10.9 $3 (m); Annex IX 2.2 [2 (b2, e); + MDD - Annex II (3.2), Annex V (3.2), Annex VI (3.2)"
"Production and Service Controls: Control, Operation, and Monitoring of the Production and Service Process; Risk Controls (MDSAP Chapter 6, Task 11, Site:
10578);
(DIN)(EN) ISO 13485 - 7.1, 7.5.1, 8.1, 8.2.5 + (DIN)(EN) ISO 9001 - 8.1, 8.5.1, 9.1.1 + MDSAP - Australia - TG(MD)R Sch1 P1 2, Sch3 P1 1.4(5)(b)&(e) +
MDSAP - Brazil - RDC ANVISA 16/2013: 2.4, 5.1.1, 5.1.6, 8.2, 9.1 + MDSAP - Japan - MO169: 26, 40, 54, 57 + MDSAP - USA - 21 CFR 820.70(a), 820.75(b),
820.250 + MDR - Article _ 10.9 [3 (m); Annex IX 2.2 2 (b2, e);"
"Production and Service Controls: Competence of Personnel (MDSAP Chapter 6, Task 12, Site: 10578);
(DIN)(EN) ISO 13485 - 6,2 + (DIN)(EN) ISO 9001 - 7.2, 7.3 + MDSAP - Australia - RDC ANVISA 16/2013: 2.3.2 + MDSAP - Japan - MO169: 22 + MDSAP -
USA - 21 CFR 820.25, 820.70(d), 820.75(b) + MDR - Annex IX2.2 1"
"Production and Service Controls: Control of Monitoring and Measuring Device (MDSAP Chapter 6, Task 13, Site: 10578);
(DIN)(EN) ISO 13485 - 7.5.1, 7.6 + (DIN)(EN) ISO 9001 - 7.1.5, 8.5.1 + MDSAP - Australia - TG(MD)R Sch3 P1 1.4(5)(e) + MDSAP - Brazil - RDC ANVISA
16/2013: 5.1.5, 5.4 + MDSAP - Japan - MO169: 40, 53 + MDSAP - USA - 21 CFR 820.70(g), 820.72 + MDR - Annex IX 2.2 2 (e); Annex XI 6.2912, 1291 +
MDD - Annex II (3.2), Annex V (3.2), Annex VI (3.2)"
"Production and Service Controls: Impact Analysis of Monitoring and Measuring Device Found Out of Specifications (MDSAP Chapter 6, Task 14, Site: 10578);
(DIN)(EN) ISO 13485 - 7,6 + (DIN)(EN) ISO 9001 - 7.1.5 + MDSAP - Australia - TG(MD)R Sch3 P1 1.4(5)(e) + MDSAP - Brazil - RDC ANVISA 16/2013: 5.4 +
MDSAP - Japan - MO169: 53 + MDSAP - USA - 21 CFR 820.72(a) + MDR - Annex IX 2.2 [2 (e); Annex XI 6.2 2, 1211 + MDD - Annex Il (3.2), Annex V (3.2),
Annex VI (3.2)"
"Production and Service Controls: Device Master File (MDSAP Chapter 6, Task 16, Site: 10578);
(DIN)(EN) ISO 13485 - 4.2.1, 4.2.3, 7.1, 7.5.8, 7.5.9.1 + (DIN)(EN) ISO 9001 - 7.5.1, 8.1, 8.5.2 + MDSAP - Australia - TG(MD)R, Sch1 EP13, Sch3 P1 1.4(5)
(c),(d),(e) & 1.9 + MDSAP - Brazil - RDC ANVISA 16/2013: 1.2.26, 2.4, 4.2, 5.2, 6.4 + MDSAP - Canada - CMDR 9(2), 21-23, 52-56, 66-68 + MDSAP - Japan -
MO169: 6, 7-2, 26, 47, 48; [Old: 6, 26, 47, 48] + MDSAP - USA - 21 CFR 820.65, 820.120(e), 820.181 + MDR - Article 10.4 1, 10.5, 10.9 {3 (b), 10.11,
10.15; Annex IX 2.2 {2 (c6); Annex X16.1 @ &12 1 +MDD - Annex II (3.2), Annex VI (3.1)"
"Production and Service Controls: Production Record; Evidence of Compliance of Released Devices _(MDSAP Chapter 6, Task 17, Site: 10578);
(DIN)(EN) ISO 13485 - 4.2.1, 7.5.1, 7.5.8, 7.5.9.1, 8.2.6 + (DIN)(EN) ISO 9001 - 7.5.1, 8.5.1, 8.5.2, 8.6 + MDSAP - Brazil - RDC ANVISA 16/2013: 3.2, 5.2, 6.4
+ MDSAP - Japan - MO169: 6, 40, 47, 48, 58, 59 + MDSAP - USA - 21 CFR 820.120, 820.184 + MDR - Article 10.7, 10.9 [3 (h); Annex IX 2.2 2 (c7); Annex XI
1241 +MDD - Annex Il (3.2), Annex V (3.2)"
"Production and Service Controls: Acceptance Activities (MDSAP Chapter 6, Task 21, Site: 10578);
(DIN)(EN) ISO 13485 - 4.2.1, 7.4.3, 7.5.8, 8.2.6 + (DIN)(EN) ISO 9001 - 7.5.1, 8.4.2, 8.4.3, 8.5.2, 8.6 + MDSAP - Australia - TG(MD)R Sch1 P1 2, Sch3 P1
CI1.4(6)(d) + MDSAP - Brazil - RDC ANVISA 16/2013: 5.3.1, 5.3.2, 5.3.3, 5.3.4, 9.2 + MDSAP - Japan - MO169: 6, 39, 47, 58, 59 + MDSAP - USA - 21 CFR
820.80, 820.250(b) + MDR - Article 10.9 [3 (m), Annex IX 2.2 [2 (b2, e); Annex XI6.2 12, 12.91 + MDD - Annex II (3.2), Annex V (3.2), Annex VI (3.2)"
"Production and Service Controls: Identification, Control, and Disposition of Nonconforming Products (MDSAP Chapter 6, Task 22, Site: 10578);
(DIN)(EN) ISO 13485 - 7.5.8, 8.3 + (DIN)(EN) ISO 9001 - 8.5.2, 8.7 + MDSAP - Australia - TG(MD)R Sch1 P1 2, Sch3 P1 Cl1.4(5)(b) + MDSAP - Brazil - RDC
ANVISA 16/2013: 6.5.1, 6.5.2 + MDSAP - Japan - MO169: 47, 60-1, 60-2, 60-3, 60-4; [Old: 47, 50, 60] + MDSAP - USA - 21 CFR 820.60, 820.90(a), 820.86,
820.100(a) + MDR - Article _ 10.9 [3 (k), 10.12; Annex IX 2.2 [2 (b2); Annex XI 6.2 2, 12 1 + MDD - Annex II (3.2), Annex V (3.2), Annex VI (3.2)"

Brief 21 Employees in Production for Kits and accessories

description of
processes or
activities
evaluated to
demonstrate
what was
audited related
to the listed
key QMS
documents
and records
reviewed
below
considering
inputs,
outputs, and
measures

ID: 31505

BU Therapy as Manufacturer within DRAGER Medical
BU HCA as marketing organisation

PSC-1 Planning of production and service process

Verified that the product realization processes are planned, including any necessary controls, controlled conditions, and
risk management activities required for the product to meet the specified or intended uses, the statutory and regulatory
requirements related to the product, and (when applicable) unique device identifier requirements.

Confirmed that the planning of product realization is consistent with the requirements of the other processes of the
quality management system and performed in consideration of the quality objectives.

Risk management in production process

United States (FDA):
DWAG PQ2140 : International Labeling Requirements - for Medical Devices DWAG PQ2140-en-04.00 , Rev. 04.00
DEMF SC6440: Labeling DEMF - SC6440 - de - 00, Rev. 0

PSC-2 Selection of production and service process(es)
Complete Production has been audited including several processes that directly impact the ability of the device to meet
its essential design outputs.

PSC-5 Infrastructure

Verified that the organization has determined and documented the infrastructure requirements to achieve product
conformity, including buildings, workspace, process equipment, and supporting services.

Confirmed that buildings, workspaces, and supporting services allow product to meet requirements.

Verified that there are documented and implemented requirements for maintenance of process equipment where
important for product quality, and that records of maintenance are maintained.

Brazil (ANVISA):

Doc No: MED_T_09.50 Revision: 12 — released Effective: 28 May 2021 Page 67 of 107
